Satoshi Tatemichi

622 total citations
39 papers, 503 citations indexed

About

Satoshi Tatemichi is a scholar working on Urology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Satoshi Tatemichi has authored 39 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Urology, 12 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Molecular Biology. Recurrent topics in Satoshi Tatemichi's work include Urinary Bladder and Prostate Research (23 papers), Hormonal and reproductive studies (9 papers) and Pelvic floor disorders treatments (6 papers). Satoshi Tatemichi is often cited by papers focused on Urinary Bladder and Prostate Research (23 papers), Hormonal and reproductive studies (9 papers) and Pelvic floor disorders treatments (6 papers). Satoshi Tatemichi collaborates with scholars based in Japan, Germany and Canada. Satoshi Tatemichi's co-authors include Mamoru Kobayashi, Yoshinobu Yamazaki, Katsuyoshi Akiyama, Nobuo Shibata, Ryoichi Yamagishi, Kazuyasu Maruyama, Masato Kitazawa, Yoshitaka Tomiyama, Hiroshi Kusama and Naoyuki Masuda and has published in prestigious journals such as PLoS ONE, Hypertension and The Journal of Urology.

In The Last Decade

Satoshi Tatemichi

38 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoshi Tatemichi Japan 12 384 184 122 113 77 39 503
Katsuyoshi Akiyama Japan 13 414 1.1× 254 1.4× 132 1.1× 74 0.7× 51 0.7× 17 549
Lawrence A. Hill United States 8 356 0.9× 164 0.9× 145 1.2× 149 1.3× 32 0.4× 16 430
Gary Hoel United States 10 471 1.2× 152 0.8× 141 1.2× 265 2.3× 114 1.5× 19 518
Yoshitaka Tomiyama Japan 15 317 0.8× 77 0.4× 234 1.9× 43 0.4× 21 0.3× 30 472
S. Meretyk Israel 8 248 0.6× 159 0.9× 137 1.1× 29 0.3× 25 0.3× 14 384
A. Thorpe United Kingdom 5 210 0.5× 73 0.4× 120 1.0× 84 0.7× 16 0.2× 12 311
Turgut Yapanoğlu Türkiye 11 97 0.3× 20 0.1× 72 0.6× 50 0.4× 13 0.2× 41 319
H.N. Blackford United Kingdom 8 140 0.4× 7 0.0× 84 0.7× 62 0.5× 35 0.5× 12 301
Teimuraz Apridonidze United States 9 32 0.1× 299 1.6× 7 0.1× 23 0.2× 100 1.3× 11 1.1k
Jie Qiao China 7 39 0.1× 135 0.7× 12 0.1× 9 0.1× 56 0.7× 14 615

Countries citing papers authored by Satoshi Tatemichi

Since Specialization
Citations

This map shows the geographic impact of Satoshi Tatemichi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Tatemichi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Tatemichi more than expected).

Fields of papers citing papers by Satoshi Tatemichi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Tatemichi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Tatemichi. The network helps show where Satoshi Tatemichi may publish in the future.

Co-authorship network of co-authors of Satoshi Tatemichi

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Tatemichi. A scholar is included among the top collaborators of Satoshi Tatemichi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Tatemichi. Satoshi Tatemichi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tatemichi, Satoshi, Atsushi Sugimura, Ryûji Yamamoto, et al.. (2020). Physicochemical and biological evaluation of JR-131 as a biosimilar to a long-acting erythropoiesis-stimulating agent darbepoetin alfa. PLoS ONE. 15(4). e0231830–e0231830. 4 indexed citations
3.
4.
5.
Tatemichi, Satoshi, et al.. (2017). PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure. PLoS ONE. 12(7). e0180430–e0180430. 11 indexed citations
6.
7.
Tatemichi, Satoshi, et al.. (2017). Alpha1A-adrenoceptor antagonist improves underactive bladder associated with diabetic cystopathy via bladder blood flow in rats. BMC Urology. 17(1). 64–64. 7 indexed citations
8.
Tomiyama, Yoshitaka, Satoshi Tatemichi, Kazuyasu Maruyama, et al.. (2016). Silodosin, an α<sub>1A</sub>-Adrenoceptor Antagonist, May Ameliorate Ischemia-Induced Bladder Denervation and Detrusor Dysfunction by Improving Bladder Blood Flow. Pharmacology. 97(3-4). 161–170. 6 indexed citations
9.
Tomiyama, Yoshitaka, et al.. (2015). Effect of silodosin, a selective α1A-adrenoceptor antagonist, on voiding behavior and bladder blood flow in a rat model of bladder outlet obstruction. European Journal of Pharmacology. 764. 489–496. 10 indexed citations
10.
11.
Igawa, Yasuhiko, Tim Schneider, Yoshinobu Yamazaki, et al.. (2012). Functional investigation of β-adrenoceptors in human isolated detrusor focusing on the novel selective β3-adrenoceptor agonist KUC-7322. Naunyn-Schmiedeberg s Archives of Pharmacology. 385(8). 759–767. 24 indexed citations
12.
Tatemichi, Satoshi, Kazuo Kobayashi, Kazuyasu Maruyama, et al.. (2012). Comparison of the Effects of Four α1-Adrenoceptor Antagonists on Ejaculatory Function in Rats. Urology. 80(2). 486.e9–486.e16. 15 indexed citations
13.
Tatemichi, Satoshi, et al.. (2012). Bladder selectivity of the novel β3-agonist ritobegron (KUC-7483) explored by in vitro and in vivo studies in the rat. Naunyn-Schmiedeberg s Archives of Pharmacology. 385(8). 845–852. 24 indexed citations
14.
Tatemichi, Satoshi, et al.. (2012). Effects of Ritobegron (KUC-7483), a Novel Selective β3-Adrenoceptor Agonist, on Bladder Function in Cynomolgus Monkey. Journal of Pharmacology and Experimental Therapeutics. 342(1). 163–168. 21 indexed citations
15.
Kobayashi, Shinya, et al.. (2009). Effects of silodosin and tamsulosin on the urethra and cardiovascular system in young and old dogs with benign prostatic hyperplasia. European Journal of Pharmacology. 613(1-3). 135–140. 15 indexed citations
16.
Tatemichi, Satoshi, Yoshitaka Tomiyama, Shinya Kobayashi, et al.. (2006). Uroselectivity in male dogs of silodosin (KMD‐3213), a novel drug for the obstructive component of benign prostatic hyperplasia. Neurourology and Urodynamics. 25(7). 792–799. 33 indexed citations
17.
Kobayashi, Mamoru, et al.. (2006). Duration of Action of Silodosin (KMD-3213) against Phenylephrine-induced Increase in Intraurethral Pressure in Rats. YAKUGAKU ZASSHI. 126(Special_Issue). 231–236. 1 indexed citations
18.
Akiyama, Katsuyoshi, Satoshi Tatemichi, Tomomi Oki, et al.. (2002). Relationship between Prostatic α<sub>1</sub>-Adrenoceptor Binding and Reduction in Intraurethral Pressure following Continuous Infusion of KMD-3213 in Rats. Pharmacology. 64(3). 140–147. 4 indexed citations
19.
Hiratochi, Masahiro, Masaya Takamoto, Satoshi Tatemichi, & Kazuo Sugane. (2000). Inhibition of interleukin 5 production with no influence on interleukin 4 production by an anti-allergic drug, tranilast, in Toxocara canis-infected mice. International Journal of Immunopharmacology. 22(6). 463–471. 11 indexed citations
20.
Moriyama, Nobuo, Hiroaki Nishimatsu, Yoshinori Tanaka, et al.. (2000). Contractile properties of urethral smooth muscles of young and aged female dogs: Morphological and pharmacological aspects. International Journal of Urology. 7(8). 298–306. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katsuyoshi Akiyama Breakdown of academic impact, for papers by Lawrence A. Hill Breakdown of academic impact, for papers by Gary Hoel Breakdown of academic impact, for papers by Yoshitaka Tomiyama Breakdown of academic impact, for papers by S. Meretyk Breakdown of academic impact, for papers by A. Thorpe Breakdown of academic impact, for papers by Turgut Yapanoğlu Breakdown of academic impact, for papers by H.N. Blackford Breakdown of academic impact, for papers by Teimuraz Apridonidze Breakdown of academic impact, for papers by Jie Qiao
Rankless by CCL
2026